Structural insights into HRI kinase activity and inhibition
1MRC Protein Phosphorylation and Ubiquitination Unit, Faculty of Life Sciences, University of Dundee, Dundee, U.K.
Biochemical Society Transactions
|May 15, 2026
Summary
Haem-regulated inhibitor (HRI) kinase is a potential target for cancer and neurodegenerative diseases. Despite its importance, its precise function and regulation remain largely unknown after 75 years.
Area of Science:
- Biochemistry
- Molecular Biology
- Cellular Stress Response
Background:
- Haem-regulated inhibitor (HRI) is a kinase involved in the integrated stress response.
- HRI phosphorylates eukaryotic initiation factor 2 alpha (eIF2α), a key regulator of mRNA translation.
- Dysregulation of HRI is implicated in diseases like multiple myeloma and neurodegenerative disorders.
Purpose of the Study:
- To review the current understanding of HRI's structural and molecular mechanisms.
- To explore the regulatory biological interactions governing HRI activity.
- To highlight the knowledge gaps in HRI function and regulation.
Main Methods:
- Literature review of recent research on HRI.
- Analysis of structural and molecular data related to HRI inhibition and activation.
- Examination of protein and cofactor interactions with HRI.
Main Results:
- HRI plays a crucial role in sensing proteotoxic stress and modulating protein synthesis.
- Research is advancing in understanding HRI's inhibition and activation pathways.
- Key regulatory interactions involving proteins and cofactors are being elucidated.
Conclusions:
- HRI is a significant therapeutic target for various diseases, including cancers and neurodegenerative conditions.
- Despite extensive research, fundamental aspects of HRI's function and regulation are still poorly understood.
- Further investigation is needed to fully elucidate HRI's role and harness its therapeutic potential.
Related Concept Videos
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:26Receptor Tyrosine Kinases
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
01:31Regulation of the Unfolded Protein Response
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
02:34Enzymes
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
02:04Protein-protein Interfaces
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...